Literature DB >> 21225391

Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.

Luna Li1, Benjamas Aiamkitsumrit, Vanessa Pirrone, Michael R Nonnemacher, Adam Wojno, Shendra Passic, Katherine Flaig, Evelyn Kilareski, Brandon Blakey, Jade Ku, Nirzari Parikh, Rushabh Shah, Julio Martin-Garcia, Brian Moldover, Laila Servance, David Downie, Sharon Lewis, Jeffrey M Jacobson, Dennis Kolson, Brian Wigdahl.   

Abstract

The long terminal repeat (LTR) regulates gene expression of HIV-1 by interacting with multiple host and viral factors. Cross-sectional studies in the pre-HAART era demonstrated that single nucleotide polymorphisms (SNPs) in peripheral blood-derived LTRs (a C-to-T change at position 3 of C/EBP site I (3T) and at position 5 of Sp site III (5T)) increased in frequency as disease severity increased. Additionally, the 3T variant correlated with HIV-1-associated dementia. LTR sequences derived by longitudinal sampling of peripheral blood from a single patient in the DrexelMed HIV/AIDS Genetic Analysis Cohort resulted in the detection of the 3T and 5T co-selected SNPs before the onset of neurologic impairment, demonstrating that these SNPs may be useful in predicting HIV-associated neurological complications. The relative fitness of the LTRs containing the 3T and/or 5T co-selected SNPs as they evolve in their native patient-derived LTR backbone structure demonstrated a spectrum of basal and Tat-mediated transcriptional activities using the IIIB-derived Tat and colinear Tat derived from the same molecular clone containing the 3T/5T LTR SNP. In silico predictions utilizing colinear envelope sequence suggested that the patient's virus evolved from an X4 to an R5 swarm prior to the development of neurological complications and more advanced HIV disease. These results suggest that the HIV-1 genomic swarm may evolve during the course of disease in response to selective pressures that lead to changes in prevalence of specific polymorphisms in the LTR, env, and/or tat that could predict the onset of neurological disease and result in alterations in viral function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225391      PMCID: PMC3057211          DOI: 10.1007/s13365-010-0014-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  35 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity.

Authors:  H L Ross; S Gartner; J C McArthur; J R Corboy; J J McAllister; S Millhouse; B Wigdahl
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

Review 3.  Predicting HIV-1 coreceptor usage with sequence analysis.

Authors:  Mark A Jensen; Angélique B van 't Wout
Journal:  AIDS Rev       Date:  2003 Apr-Jun       Impact factor: 2.500

4.  Quality scores and SNP detection in sequencing-by-synthesis systems.

Authors:  William Brockman; Pablo Alvarez; Sarah Young; Manuel Garber; Georgia Giannoukos; William L Lee; Carsten Russ; Eric S Lander; Chad Nusbaum; David B Jaffe
Journal:  Genome Res       Date:  2008-01-22       Impact factor: 9.043

5.  Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.

Authors:  Tricia H Hogan; Devin L Stauff; Fred C Krebs; Suzanne Gartner; Shane J Quiterio; Brian Wigdahl
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

6.  Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.

Authors:  J J McAllister; D Phillips; S Millhouse; J Conner; T Hogan; H L Ross; B Wigdahl
Journal:  Virology       Date:  2000-09-01       Impact factor: 3.616

7.  A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Robert F Rando; Mohamed Labib; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2010-05-31

8.  Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques.

Authors:  Siu-hong Ho; Silvana Tasca; Lili Shek; Amy Li; Agegnehu Gettie; James Blanchard; Daniel Boden; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

9.  Restricted HIV-1 replication in placental macrophages is caused by inefficient viral transcription.

Authors:  K García-Crespo; C Cadilla; R Skolasky; L M Meléndez
Journal:  J Leukoc Biol       Date:  2009-12-30       Impact factor: 4.962

10.  Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.

Authors:  Leonie A Boven; Farshid Noorbakhsh; Gerben Bouma; Ruurd van der Zee; Diana L Vargas; Carlos Pardo; Justin C McArthur; Hans S L M Nottet; Christopher Power
Journal:  J Neurovirol       Date:  2007-04       Impact factor: 2.643

View more
  22 in total

Review 1.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

Review 2.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

Review 3.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 4.  HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.

Authors:  Melissa J Churchill; Daniel J Cowley; Steve L Wesselingh; Paul R Gorry; Lachlan R Gray
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

Review 5.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.

Authors:  Will Dampier; Gregory C Antell; Benjamas Aiamkitsumrit; Michael R Nonnemacher; Jeffrey M Jacobson; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Tony James; Kathryn N Devlin; Tania Giovannetti; David J Libon; Zsofia Szep; Garth D Ehrlich; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

7.  HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.

Authors:  Will Dampier; Michael R Nonnemacher; Neil T Sullivan; Jeffrey M Jacobson; Brian Wigdahl
Journal:  MOJ Immunol       Date:  2014-10-17

8.  Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

Authors:  Robert W Link; Anthony R Mele; Gregory C Antell; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Zsofia Szep; Kim Malone; Jeffrey M Jacobson; Will Dampier; Brian Wigdahl; Michael R Nonnemacher
Journal:  Virus Res       Date:  2019-08-19       Impact factor: 3.303

Review 9.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

10.  Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort.

Authors:  Nirzari Parikh; Will Dampier; Rui Feng; Shendra R Passic; Wen Zhong; Brian Frantz; Brandon Blakey; Benjamas Aiamkitsumrit; Vanessa Pirrone; Michael R Nonnemacher; Jeffrey M Jacobson; Brian Wigdahl
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.